Skip to main content
. 2017 Dec 8;17:182. doi: 10.1186/s12890-017-0518-z

Table 1.

Demographic and clinical characteristics of patients before and after CPAP therapy (n = 34)

Variables Before CPAP After CPAP p-value
Age 55.2 (7.9)
BMI 31.2 (4.1) 31.3 (4.0) 0.901
Smoking 7 (20.6)
ESS >10 8.4 (4.3) 4.8 (2.7) <0.001*
AHI (events/h) 35.2 (18.8) 2.6 (2.3) <0.001
ODI (events/h) 25.5 (20.0)
Mean SaO2 (%) 92.1 (2.1)
Lower SaO2 (%) 79.8 (8.5)
SaO2 < 90% (%) 17.7 (18.5)
Total cholesterol, mg/dl 198.2 (32.9) 187.4 (36.0) 0.021
HDL-cholesterol, mg/dl 44.3 (10.3) 44.5 (11.0) 0.678
LDL-cholesterol, mg/dl 131.0 (29.4) 121.5 (30.8) 0.031
Triglycerides, mg/dl 137.9 (51.0) 126.6 (59.6) 0.124
Glucose, mg/dl 98.7 (12.8) 98.2 (11.7) 0.924
HbA1c, % 5.7 (0.4) 5.8 (0.4) 0.064
24 h SBP (mm Hg) 129.8 (10.5) 128.0 (10.3) 0.287
24 h DBP (mm Hg) 82.4 (7.1) 79.2 (6.4) 0.004
Pulse pressure (mm Hg) 47.4 (7.3) 48.8 (8.1) 0.050
24 h MBP (mm Hg) 97.4 (7.9) 94.9 (7.2) 0.030
Day-time SBP (mm Hg) 133.3 (10.5) 131.2 (10.9) 0.214
Day-time DBP (mm Hg) 85.4 (7.3) 81.6 (6.9) 0.001
Night-time SBP (mm Hg) 117.9 (12.6) 116.4 (9.5) 0.363
Night-time DBP (mm Hg) 72.1 (9.1) 70.1 (5.9) 0.169
Hypertension n (%) 27 (79.4) 25 (73.5) 0.500*
Antihypertensive drugs, n (%) 21 (61.8)
Dyslipidaemia n (%) 28 (82.4) 24 (70.6) 0.125*
Lipid lowering drugs n (%) 14 (41.2)
MetS n (%) 21 (61.8) 20 (58.8) 1.000*
Cf-PWV (m/s) 12.3 (2.3) 11.7 (1.8) 0.086

Results are expressed as mean (standard deviation); *p-values obtained by McNemar test; remaining p-values were obtained by Wilcoxon rank exact test

CPAP continuous positive airway treatment, BMI Body mass index, ESS Epworth Sleepiness Scale, AHI Apnea/Hypopnea Index, ODI Oxygen Desaturation Index, SaO 2 arterial oxygen saturation, HbA1c glycated haemoglobin, SBP systolic blood pressure, DBP diastolic blood pressure, MetS metabolic syndrome, cf-PWV carotid-femoral pulse wave velocity